Skip to main content
. 2018 Apr 13;9(28):19543–19554. doi: 10.18632/oncotarget.24646

Figure 2. Significant reductions of pancreatic volumes and pancreatic exocrine functions in the TBI-based group compared with almost unchanged pancreatic volumes and functions in the MCHT-based group.

Figure 2

MCHT, myeloablative chemotherapy; DFO, deferoxamine; TBI, total body irradiation; HSCT, hematopoietic stem cell transplantation.